Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06140784 · ClinicalTrials.gov registry record · NA
A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT06140784 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 116 participants.
The verdict
NCT06140784, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the effect four different dentifrices have on gingivitis after 12 weeks of product use. The secondary objectives are to assess the effect four dentifrices, have on plaque and oral microbiome composition.
Interventions
- DRUG 0.76% Sodium Monofluorophosphate Dentifrice
- DRUG 0.454% Stannous Fluoride Dentifrice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2023-09-02 |
| Est. Completion | 2023-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06140784
The ClinicalTrials.gov registry entry for NCT06140784 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 0.76% Sodium Monofluorophosphate Dentifrice is the first listed.
NCT06140784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06140784 about?
NCT06140784 is a clinical study titled "A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices". The primary objective of this study is to evaluate the effect four different dentifrices have on gingivitis after 12 weeks of product use. The secondary objectives are to assess the effect four dentifrices, have on plaque and oral microbiome composition.
What is the current status of trial NCT06140784?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2023-09-02. Estimated completion is 2023-12-10.
What interventions are being tested in trial NCT06140784?
The interventions under investigation include: 0.76% Sodium Monofluorophosphate Dentifrice (DRUG), 0.454% Stannous Fluoride Dentifrice (DRUG).
Who is sponsoring clinical trial NCT06140784?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.